Mubadala Investment Company, an Abu Dhabi sovereign investor, agreed to invest in Resilience, a technology-focused manufacturing company dedicated to broadening access to complex medicines. Financial terms were not disclosed. "We are excited to expand the footprint of our Resilience manufacturing network outside of North America. This is a significant milestone, not just for our company but also for our nation. We look forward to working alongside America’s allies in the region to ensure that trusted, cutting-edge biopharmaceutical manufacturing capacity is available to support local, regional, and global economies," Rahul Singhvi, Resilience CEO.